VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+1.08%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(+62%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
38.38%
Top 10 Holdings %
Top 10 Hldgs %
47.51%
Holding
205
New
53
Increased
79
Reduced
42
Closed
30
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$24M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
$11.9M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
$7.87M |
| 4 |
WPZ
Williams Partners L.P.
WPZ
|
$7.16M |
| 5 |
EEP
Enbridge Energy Partners
EEP
|
$5.92M |
Top Sells
| 1 |
Williams Companies
WMB
|
$1.75M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.69M |
| 3 |
ProShares Ultra 20+ Year Treasury
UBT
|
$1.24M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$1.06M |
| 5 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$1.02M |
Sector Composition
| 1 | Energy | 57.29% |
| 2 | Healthcare | 12.14% |
| 3 | Utilities | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Hawaiian Electric Industries
HE
$2.24B
| $365K | 0.11% |
+11,050
| New | +$365K |
|
102
Vanguard Real Estate ETF
VNQ
$34.6B
| $361K | 0.11% |
4,373
-9,618
| -69% | -$794K |
|
|
AGR
103
DELISTED
Avangrid, Inc.
AGR
| $352K | 0.11% |
+9,298
| New | +$352K |
|
104
Cheniere Energy
CQP
$26.7B
| $340K | 0.1% |
11,804
-5,783
| -33% | -$167K |
|
|
SGYP
105
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $336K | 0.1% |
55,250
-13,004
| -19% | -$79.1K |
|
|
NS
106
DELISTED
NuStar Energy L.P.
NS
| $332K | 0.1% |
6,673
+2,065
| +45% | +$103K |
|
107
New Jersey Resources
NJR
$4.75B
| $316K | 0.09% |
+8,900
| New | +$316K |
|
|
CLVS
108
DELISTED
Clovis Oncology, Inc.
CLVS
| $313K | 0.09% |
7,054
-10,811
| -61% | -$480K |
|
|
PTLA
109
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $312K | 0.09% |
13,895
+4,160
| +43% | +$93.4K |
|
|
LOXO
110
DELISTED
Loxo Oncology, Inc
LOXO
| $302K | 0.09% |
9,411
-820
| -8% | -$26.3K |
|
111
Oneok
OKE
$48.1B
| $297K | 0.09% |
5,181
+1,590
| +44% | +$91.1K |
|
|
KA
112
DELISTED
Kineta, Inc. Common Stock
KA
| $296K | 0.09% |
+24,169
| New | +$296K |
|
113
BioCryst Pharmaceuticals
BCRX
$1.74B
| $291K | 0.09% |
46,010
-38,897
| -46% | -$246K |
|
|
PRTK
114
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $281K | 0.08% |
+18,271
| New | +$281K |
|
115
Seres Therapeutics
MCRB
$166M
| $279K | 0.08% |
28,148
+20,050
| +248% | +$199K |
|
|
SEP
116
DELISTED
Spectra Engy Parters Lp
SEP
| $278K | 0.08% |
6,075
+1,870
| +44% | +$85.6K |
|
|
EPZM
117
DELISTED
Epizyme, Inc
EPZM
| $277K | 0.08% |
22,900
+1,150
| +5% | +$13.9K |
|
118
Cytokinetics
CYTK
$4.23B
| $273K | 0.08% |
22,494
-6,885
| -23% | -$83.6K |
|
|
TVRD
119
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $272K | 0.08% |
+29,288
| New | +$272K |
|
|
BPMC
120
DELISTED
Blueprint Medicines
BPMC
| $271K | 0.08% |
9,665
-3,381
| -26% | -$94.8K |
|
121
Neurogene
NGNE
$264M
| $270K | 0.08% |
+16,347
| New | +$270K |
|
122
Xencor
XNCR
$580M
| $270K | 0.08% |
10,262
-7,387
| -42% | -$194K |
|
|
SAGE
123
DELISTED
Sage Therapeutics
SAGE
| $269K | 0.08% |
5,277
-3,497
| -40% | -$178K |
|
|
JUNO
124
DELISTED
Juno Therapeutics, Inc.
JUNO
| $267K | 0.08% |
14,153
+8,136
| +135% | +$153K |
|
125
FibroGen
FGEN
$47.8M
| $266K | 0.08% |
12,435
-2,431
| -16% | -$52K |
|